OTLK - Outlook stock rallies on private placement FDA study agreement
2024-01-23 09:45:09 ET
More on Outlook Therapeutics
- Outlook Therapeutics GAAP EPS of -$0.24
- Outlook Therapeutics appoints new head of licensing and M&A
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics
- Financial information for Outlook Therapeutics